Givosiran (Givlaari) Market: Revenue Analysis, Clinical Adoption Trends, Reimbursement Landscape, And Competitive Benchmarking, 2025 - 2033
- Published: Nov, 2025
- Report ID: GVR-MT-100515
- Format: PDF/Excel databook
- No. of Pages/Datapoints: 120
- Report Coverage: 2024 - 2030
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Givosiran (Givlaari) Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Pricing Analysis
Chapter 4. Givosiran (Givlaari) Market: Treatment Type Business Analysis
4.1. Treatment Type Market Share, 2024 & 2033
4.2. Treatment Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Treatment Type, 2021 to 2033 (USD Million)
4.4. RNA Interference (RNAi)-Based Therapeutics
4.4.1. RNA Interference (RNAi)-Based Therapeutics Market Size & Forecasts and Trend Analysis, by Treatment Type, 2021 to 2033 (USD Million)
4.5. Conventional Therapies (Hemin-Based)
4.5.1. Conventional Therapies (Hemin-Based) Market Size & Forecasts and Trend Analysis, by Treatment Type, 2021 to 2033 (USD Million)
Chapter 5. Givosiran (Givlaari) Market: Distribution Channel Business Analysis
5.1. Distribution Channel Market Share, 2024 & 2033
5.2. Distribution Channel Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
5.4. Hospital Pharmacies
5.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Million)
5.5. Specialty Pharmacies
5.5.1. Specialty Pharmacies, 2021 - 2033 (USD Million)
5.6. Others
5.6.1. Others, 2021 - 2033 (USD Million)
Chapter 6. Givosiran (Givlaari) Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2033
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
6.4. North America
6.5. Europe
6.6. Asia Pacific
6.7. Latin America
6.8. Middle East and Africa
Chapter 7. Competitive Landscape
7.1. Company Profile
7.1.1. Alnylam Pharmaceuticals, Inc.
7.1.1.1. Overview
7.1.1.2. Financial Performance
7.1.1.3. Strategic Mapping
7.2. Concurrent Competitive Landscape
7.2.1. Recordati Rare Diseases Inc.
7.2.1.1. Overview
7.2.1.2. Financial Performance
7.2.1.3. Product Benchmarking
7.2.1.4. Strategic Mapping
7.2.2. Orphan Europe (Recordati Group)
7.2.2.1. Overview
7.2.2.2. Financial Performance
7.2.2.3. Product Benchmarking
7.2.2.4. Strategic Mapping
7.2.3. Ionis Pharmaceuticals, Inc.
7.2.3.1. Overview
7.2.3.2. Financial Performance
7.2.3.3. Product Benchmarking
7.2.3.4. Strategic Mapping
7.2.4. Arrowhead Pharmaceuticals, Inc.
7.2.4.1. Overview
7.2.4.2. Financial Performance
7.2.4.3. Product Benchmarking
7.2.4.4. Strategic Mapping
7.2.5. Moderna, Inc.
7.2.5.1. Overview
7.2.5.2. Financial Performance
7.2.5.3. Product Benchmarking
7.2.5.4. Strategic Mapping
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global Givosiran (Givlaari) Market, by region, 2021 - 2033 (USD Million)
Table 4. North America Givosiran (Givlaari) Market, by Treatment Type, 2021 - 2033 (USD Million)
Table 5. North America Givosiran (Givlaari) Market, by Distribution Channel, 2021 - 2033 (USD Million)
Table 6. Europe Givosiran (Givlaari) Market, by Treatment Type, 2021 - 2033 (USD Million)
Table 7. Europe Givosiran (Givlaari) Market, by Distribution Channel, 2021 - 2033 (USD Million)
Table 8. Asia Pacific Givosiran (Givlaari) Market, by Treatment Type, 2021 - 2033 (USD Million)
Table 9. Asia Pacific Givosiran (Givlaari) Market, by Distribution Channel, 2021 - 2033 (USD Million)
Table 10. Latin America Givosiran (Givlaari) Market, by Treatment Type, 2021 - 2033 (USD Million)
Table 11. Latin America Givosiran (Givlaari) Market, by Distribution Channel, 2021 - 2033 (USD Million)
Table 12. Middle East & Africa Givosiran (Givlaari) Market, by Treatment Type, 2021 - 2033 (USD Million)
Table 13. Middle East Givosiran (Givlaari) Market, by Distribution Channel, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Givosiran (Givlaari) Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market End User & validation
Fig. 8 Market snapshot
Fig. 9 Treatment Type outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Givosiran (Givlaari) Market dynamics
Fig. 12 Givosiran (Givlaari) Market: Porter’s five forces analysis
Fig. 13 Givosiran (Givlaari) Market: PESTLE analysis
Fig. 14 Treatment Type market, 2021 - 2033 (USD Million)
Fig. 15 RNA Interference (RNAi)-Based Therapeutics market, 2021 - 2033 (USD Million)
Fig. 16 Conventional Therapies (Hemin-Based) market, 2021 - 2033 (USD Million)
Fig. 17 Distribution Channel market, 2021 - 2033 (USD Million)
Fig. 18 Hospital Pharmacies market, 2021 - 2033 (USD Million)
Fig. 19 Specialty Pharmacies market, 2021 - 2033 (USD Million)
Fig. 20 Others market, 2021 - 2033 (USD Million)
Fig. 21 Givosiran (Givlaari) Market revenue, by region
Fig. 22 Regional marketplace: Key takeaways
Fig. 23 North America Givosiran (Givlaari) Market, 2021 - 2033 (USD Million)
Fig. 24 Europe Givosiran (Givlaari) Market, 2021 - 2033 (USD Million)
Fig. 25 Asia Pacific Givosiran (Givlaari) Market, 2021 - 2033 (USD Million)
Fig. 26 Latin America Givosiran (Givlaari) Market, 2021 - 2033 (USD Million)
Fig. 27 MEA Givosiran (Givlaari) Market, 2021 - 2033 (USD Million)
Fig. 28 Company categorization
Fig. 29 Company market position analysis
Fig. 30 Strategic framework
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.